High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.9M
$1,877,016
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-04
$745,984x8
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-04 | $745,984x8 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-03-02
$523,584x10
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-03-02 | $523,584x10 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Tanguler Tolga
• Officer • EVP, Chief Commercial Officer
Sell to Cover
2026-02-13
$607,448
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
Officer • EVP, Chief Commercial Officer
Sell to Cover
|
2026-02-13 | $607,448 | S | Form 4 |